ResearchMoz

Orthobiologics Market (Allografts, Viscosupplements, DBM, BMP, Stem Cell and Others) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019

Transparency Market Research
Published Date » 2013-12-20
No. Of Pages » 105
Orthobiology is a branch of science that develops bone and tissue replacement materials for skeletal and tissue healing. Orthobiologics has been gaining popularity since it provides accelerated healing, faster recovery and reduction in number of hospital visits. A rise in the incidence of arthritis and geriatric population has triggered the growth of this market. Moreover, increase in obesity rate coupled with rise in demand for minimally invasive procedures has created a considerable demand for bone graft substitutes. In addition, technological advancements, growing patient awareness, rising incidences of road accidents and rising participation in sports related activities has considerably augmented the growth of this market.

The research report on orthobiologics provides detailed analysis of the global market and helps in understanding the driving forces responsible for the growth of this market. The report discusses the market of orthobiologics on the basis of different orthobiologic products and applications. The product segment comprises allografts, demineralized bone matrix (DBM), bone morphogenetic proteins (BMPs), viscosupplementation, synthetic bone graft substitutes, stem cell based products and machined bone. The application segment is classified into spinal fusion, trauma and reconstructive surgeries. Market size estimates and forecasts for the period 2011 to 2019 have been provided for each of the segments, in terms of USD million, using 2012 as the base year. The CAGR (%) of each market segment for the forecast period 2013 to 2019 has been provided along with market size estimations.

The market has also been segmented geographically into four regions, namely, North America, Europe, Asia-Pacific and Rest of the World (RoW), and the respective market sizes and forecasts have been provided for each of these regions. A detailed qualitative analysis of the factors responsible for driving and restraining growth of the global orthobiologics market, and future opportunities has been provided in the market overview section. This section also features a detailed market attractiveness analysis and Porter’s five force analysis for the orthobiologics market.

The market players are profiled on the basis of various attributes such as company overview, financial overview, business strategies, product portfolio and recent developments. Some of the major players profiled in this report include Medtronic, Inc., Stryker Corporation., DePuySythes, Wright Medical Technology, Inc., NuVasive, Inc., Orthofix, Inc., and others.
The global orthobiologicsmarket is segmented into the following categories:

OrthobiologicsMarket, by Products
  • Allografts
  • Machined Bones
  • Demineralized Bone Matrix (DBM)
  • Bone Morphogenetic Proteins (BMPs)
  • Viscosupplementation
  • Stem Cell Therapy
  • Synthetic Bone Substitutes
OrthobiologicsMarket, by Applications
  • Spinal Fusion
  • Trauma
  • Reconstructive Surgery
Orthobiologics Market, by Geography
  • North America
  • Europe
  • Asia-Pacific
  • RoW
Table of Content

Chapter 1 Preface
1.1 Report Description
1.2 Market Segmentation
1.3 Research Methodology
1.3.1 Assumptions

Chapter 2 Executive Summary
2.1 Market Snapshot: Global Orthobiologics Market (2012 & 2019)
2.2 Global Orthobiologics Market, by Products, 2012 (USD Million)
2.3 Global Orthobiologics Market, by Applications, 2012 (USD Million)

Chapter 3 Market Overview
3.1 Introduction
3.1.1 Market Drivers
3.1.1.1 Rising prevalence of chronic arthritis and rapidly aging world population
3.1.1.2 Surge in sports injuries
3.1.1.3 Surge in the number of orthopedic surgeries
3.1.1.4 Technological advances in bone graft materials to boost market growth
3.1.1.5 Demand for innovative products to bolster the growth of the market
3.1.2 Restraints
3.1.2.1 Lack of Reimbursement
3.1.2.2 Stringent regulatory requirements to restrain market growth
3.1.3 Opportunities
3.1.3.1 Rise in cell based matrices
3.1.3.2 Emerging markets
3.2 Porter’s Five Force Analysis: Global Orthobiologics Market
3.2.1 Bargaining Power of Suppliers
3.2.2 Bargaining Power of Buyers
3.2.3 Threat of New Entrants
3.2.4 Threat of Substitutes
3.2.5 Competitive Rivalry
3.3 Market Attractiveness Analysis of the Global Orthobiologics Market, by Geography

Chapter 4 Global Orthobiologics Market, by Product
4.1 Overview
4.1.1 Global Orthobiologics Market, by Products, 2011 – 2019 (USD Million)
4.2 Bone Morphogenetic Proteins
4.2.1 Global Bone Morphogenetic Proteins Product Market, 2011 – 2019 (USD Million)
4.3 Demineralized Bone Matrix (DBM)
4.3.1 Global Demineralized Bone Matrix Product Market, 2011 – 2019 (USD Million)
4.4 Synthetic Bone Substitutes
4.4.1 Global Synthetic Bone Substitutes Product Market, 2011 – 2019 (USD Million)
4.5 Viscosupplementation
4.5.1 Global Viscosupplementation Product Market, 2011 – 2019 (USD Million)
4.6 Allograft
4.6.1 Global Allografts Product Market, 2011 – 2019 (USD Million)
4.7 Stem Cell Therapy
4.7.1 Global Stem Cell Therapy Product Market, 2011 – 2019 (USD Million)
4.8 Machined Bones
4.8.1 Global Machined Bones Product Market, 2011 – 2019 (USD Million)

Chapter 5 Global Orthobiologics Market, by Application
5.1 Overview
5.1.1 Global Orthobiologics Market, by Applications, 2011 – 2019 (USD Million)
5.2 Spinal Fusion
5.2.1 Global Spinal Fusion Application Market, 2011 – 2019 (USD Million)
5.3 Trauma
5.3.1 Global Trauma Application Market, 2011 – 2019 (USD Million)
5.4 Reconstructive surgery
5.4.1 Global Reconstructive Surgery Application Market, 2011 – 2019 (USD Million)

Chapter 6 Global Orthobiologics Market, by Geography
6.1 Overview
6.1.1 Global Orthobiologics Market, by Geography, 2011 – 2019 (USD Million)
6.2 Comparative Analysis: Orthobiologics Market, by Geography, 2012 & 2019 (Value %)
6.3 North America
6.3.1 North America Orthobiologics Market, by Product, 2011 – 2019 (USD Million)
6.3.2 North America Orthobiologics Market, by Application, 2011 – 2019 (USD Million)
6.4 Europe
6.4.1 Europe Orthobiologics Market, by Product, 2011 – 2019 (USD Million)
6.4.2 Europe Orthobiologics Market, by Application, 2011 – 2019 (USD Million)
6.5 Asia-Pacific
6.5.1 Asia-Pacific Orthobiologics Market, by Product, 2011 – 2019 (USD Million)
6.5.2 Asia-Pacific Orthobiologics Market, by Application, 2011 – 2019 (USD Million)
6.6 RoW
6.6.1 RoW Orthobiologics Market, by Product, 2011 – 2019 (USD Million)
6.6.2 RoW Orthobiologics Market, by Application, 2011 – 2019 (USD Million)

Chapter 7 Global Orthobiologics Market Share Analysis
7.1 Market Share Analysis by Key Players of Global Orthobiologics Market
7.1.1 Global Orthobiologics Market Share Analysis, by Key Players, 2012 (%)

Chapter 8 Recommendations
8.1 Success strategies
8.1.1 Rigorous research and development (R&D) initiatives
8.1.2 Investing in emerging economies
8.2 Barriers to be considered
8.2.1 Significant Cost of Investment

Chapter 9 Company Profiles
9.1 Alphatec Spine, Inc.
9.1.1 Business Overview
9.1.2 Financial Overview
9.1.3 Product Portfolio
9.1.4 Business Strategies
9.1.5 Recent Developments
9.2 Bacterin International, Inc.
9.2.1 Business Overview
9.2.2 Financial Overview
9.2.3 Product Portfolio
9.2.4 Business Strategies
9.2.5 Recent Developments
9.3 Biomet, Inc.
9.3.1 Business overview
9.3.2 Financial Overview
9.3.3 Product Portfolio
9.3.4 Business Strategies
9.4 DePuy Synthes, Inc. (A Johnson & Johnson Company)
9.4.1 Business Overview
9.4.2 Financial Overview
9.4.3 Product Portfolio
9.4.4 Business Strategies
9.4.5 Recent Developments
9.5 Exactech, Inc.
9.5.1 Business Overview
9.5.2 Financial Overview
9.5.3 Product Portfolio
9.5.4 Business Strategies
9.5.5 Recent Developments
9.6 Globus Medical, Inc.
9.6.1 Business Overview
9.6.2 Financial Overview
9.6.3 Product Portfolio
9.6.4 Business Strategies
9.6.5 Recent Developments
9.7 Integra LifeSciences Corporation
9.7.1 Business Overview
9.7.2 Financial Overview
9.7.3 Product Portfolio
9.7.4 Business Strategies
9.7.5 Recent Developments
9.8 Medtronic, Inc.
9.8.1 Business Overview
9.8.2 Financial Overview
9.8.3 Product Portfolio
9.8.4 Business Strategies
9.8.5 Recent Developments
9.9 NuVasive, Inc.
9.9.1 Business Overview
9.9.2 Financial Overview
9.9.3 Product Portfolio
9.9.4 Business Strategies
9.9.5 Recent Developments
9.10 Orthofix Holdings, Inc.
9.10.1 Business Overview
9.10.2 Financial Overview
9.10.3 Products Portfolio
9.10.4 Business Strategies
9.10.5 Recent Developments
9.11 Regeneration Technologies, Inc.
9.11.1 Business Overview
9.11.2 Financial Overview
9.11.3 Product Portfolio
9.11.4 Business Strategies
9.11.5 Recent Developments
9.12 Sanofi
9.12.1 Business Overview
9.12.2 Financial Overview
9.12.3 Product Portfolio
9.12.4 Business Strategies
9.12.5 Recent Developments
9.13 Stryker Corporation
9.13.1 Business Overview
9.13.2 Financial Overview
9.13.3 Product Portfolio
9.13.4 Business Strategies
9.13.5 Recent Developments
9.14 Wright Medical Technology, Inc.
9.14.1 Business Overview
9.14.2 Financial Overview
9.14.3 Product Portfolio
9.14.4 Business Strategies
9.14.5 Recent Developments
9.15 Zimmer Holdings, Inc.
9.15.1 Business Overview
9.15.2 Financial Overview
9.15.3 Product Portfolio
9.15.4 Business Strategies
9.15.5 Recent Developments

List of Tables

TABLE 1 Market Snapshot: Global Orthobiologics Market (2012 & 2019)
TABLE 2 Global Orthobiologics Market, by Products, 2011 – 2019 (USD Million)
TABLE 3 Global Orthobiologics Market, by Applications, 2011 – 2019 (USD Million)
TABLE 4 Global Orthobiologics Market, by Geography, 2011 – 2019 (USD Million)
TABLE 5 North America Orthobiologics Market, by Products, 2011 – 2019 (USD Million)
TABLE 6 North America Orthobiologics Market, by Applications, 2011 – 2019 (USD Million)
TABLE 7 Europe Orthobiologics Market, by Products, 2011 – 2019 (USD Million)
TABLE 8 Europe Orthobiologics Market, by Applications, 2011 – 2019 (USD Million)
TABLE 9 Asia-Pacific Orthobiologics Market, by Products, 2011 – 2019 (USD Million)
TABLE 10 Asia-Pacific Orthobiologics Market, by Applications, 2011 – 2019 (USD Million)
TABLE 11 RoW Orthobiologics Market, by Products, 2011 – 2019 (USD Million)
TABLE 12 RoW Orthobiologics Market, by Applications, 2011 – 2019 (USD Million)

List of Figures


FIG. 1 Orthobiologics: Market Segmentation
FIG. 2 Global Orthobiologics Market, by Products, 2012 (USD Million)
FIG. 3 Global Orthobiologics Market, by Application, 2012 (USD Million)
FIG. 4 Porter’s Five Force Analysis: Global Orthobiologics Market
FIG. 5 Market Attractiveness Analysis: Global Orthobiologics Market, by Geography
FIG. 6 Global Bone Morphogenetic Protein Products, 2011 – 2019 (USD Million)
FIG. 7 Global Demineralized Bone Matrix Products, 2011 – 2019 (USD Million)
FIG. 8 Global Synthetic Bone Substitute Products, 2011 – 2019 (USD Million)
FIG. 9 Global Viscosupplementation Products, 2011 – 2019 (USD Million)
FIG. 10 Global Allograft Products, 2011 – 2019 (USD Million)
FIG. 11 Global Stem Cell Therapy Products, 2011 – 2019 (USD Million)
FIG. 12 Global Machined Bone Products, 2011 – 2019 (USD Million)
FIG. 13 Global Spinal Fusion Application Market, 2011 – 2019 (USD Million)
FIG. 14 Global Trauma Application Market, 2011 – 2019 (USD Million)
FIG. 15 Global Reconstructive Surgery Application Market, 2011 – 2019 (USD Million)
FIG. 16 Comparative Analysis: Orthobiologics Market, by Geography, 2012 & 2019 (Value %)
FIG. 17 Global Orthobiologics: Market Share, by Key Players, 2012 (%)
FIG. 18 Alphatec Spine, Inc., Annual Revenue: 2010 – 2012 (USD Million)
FIG. 19 Bacterin International Holdings, Inc., Annual Revenue: 2010– 2012 (USD Million)
FIG. 20 Biomet, Inc., Annual Revenue: 2010 – 2012 (USD Million)
FIG. 21 Johnson & Johnson, Annual Revenue: 2010 – 2012 (USD Million)
FIG. 22 Exactech, Inc., Annual Revenue: 2010 – 2012 (USD Million)
FIG. 23 Globus Medical, Inc., Annual Revenue: 2010 – 2012 (USD Million)
FIG. 24 Integra LifeSciences Corporation, Annual Revenue: 2010 – 2012 (USD Million)
FIG. 25 Medtronic, Inc., Annual Revenue: 2010 – 2012 (USD Million)
FIG. 26 NuVasive, Inc., Annual Revenue: 2010 – 2012 (USD Million)
FIG. 27 Orthofix Holdings, Inc., Annual Revenue: 2010-2012 (USD Million)
FIG. 28 Regeneration Technologies, Inc., Annual Revenue: 2010 – 2012 (USD Million)
FIG. 29 Sanofi, Annual Revenue: 2010 – 2012 (USD Million) (1 Euro= 1.31 USD)
FIG. 30 Stryker Corporation, Annual Revenue: 2010 – 2012 (USD Million)
FIG. 31 Wright Medical Technology, Inc.: Annual Revenue 2010 – 2012 (USD Million)
FIG. 32 Zimmer Holdings. Inc, Annual Revenue: 2010 – 2012 (USD Million)

Upcoming Reports:

Baby Food Packaging Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2012 - 2018
By - Transparency Market Research
The baby food packaging market has trends evolving from the use of plastics for making baby food containers, boxes, and pouches. It has new features like packaging rice puffs, crackers and cereals in boxes of various types such as card sleeve and jumbo packs. Foods like oatmeal infant cereals and dry rice in small quantities are packed in pouches.  Baby food traditionally came in glass jars but now packaging has shifted to plastics and other materials for their easy storage and lower cost. Packaging of baby food depends on the type of baby food like dried, prepared,...
High-Density Polyethylene (HDPE) Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019
By - Transparency Market Research
High-density polyethylene (HDPE) is widely used commodity plastic and a member of polyolefin group. HDPE is nothing but the polyethylene material having high strength to density ratio. HDPE backbone chain has little side branches, which imparts greater intermolecular forces resulting in higher mechanical properties than that of low-density polyethylene (LDPE). HDPE is opaque material.  It has working temperature up to 110°C to 115°C. HDPE is synthesized using special catalysts such as Ziegler-Natta catalyst to introduce side branching. HDPE is thermoplastic material and...
Video Telemedicine Market - Global Industry Size, Market Share, Trends Analysis And Forecast, 2012 - 2018
By - Transparency Market Research
The term telemedicine refers to the utilization of telecommunication technologies in the healthcare industry. Doctors use such technologies to diagnose or treat a patient remotely. Video telemedicine deals with that part of the telemedicine market, which is done through video conferencing. The global telemedicine market was estimated to be USD 740 million in 2011. The market will grow to reach USD 877.50 million in 2012, and will grow at an estimated CAGR of 18.58% from 2012 to 2018, to reach USD 2440 million by 2018. The U.S and Europe hold the majority of the market...

Research Assistance

We will be happy to help you find what you need.
Please call us or write us:

866-997-4948 (Us-Canada Toll Free)
Tel: +1-518-618-1030
Email: sales@researchmoz.us
Select License type:

Share this report

Related News

India is Facing a Cancer Crisis
Apr 15, 2014  
India is currently facing a cancer crisis – reports a recent research carried out at the King’s college London, in collaboration with the Tata Memorial Cancer Centre, Mumbai.  The reasons estimated for this crisis comprise of increasing rates of smoking, unequal access to proper treatment and belated diagnosis.  Every year, India witnesses around one...
Microparticle Tags to Check Counterfeit Goods Invented
Apr 14, 2014  
Researchers from the Massachusetts Institute of Technology have invented a new set of microparticles that can easily be read by smartphones and establish the authenticity of currency, electronic items and luxury goods.  This strategy is among those countless measures taken by big brands and companies to label their legitimate products in order to stop illegal copies of the...
USFDA Approves Lupins Generic Diabetic Drug
Apr 10, 2014  
The United States Food and Drugs Administration (USFDA) has finally approved Lupin Pharmaceuticals Inc (LPI), the American subsidiary of Indian drug manufacturers Lupin Ltd, to sell Pioglitazone Tablets in the U.S market. The approval has been granted first for fiscal 2015.  Pioglitazone is a generic medicine used for managing diabetes and is a version of Actos tablets...
Infrared Sensors can Soon Be Used to Develop Night-Vision Lenses - A New Discovery Confirms
Apr 8, 2014  
People who fear the dark may soon have a reason to rejoice – an infrared sensor that can eventually be used for mechanizing night-vision lenses has been developed. This effectively means that one can also see through dark with the help of these lenses.  This technology seems possible all due to graphene, a layer of tightly packed carbon atoms that has allowed the creation of...
Ontarios thanks Sustainable Development Technology Canada for Clean Tech Ecosystem Movements
Apr 8, 2014  
Sustainable Development Technology Canada has leveraged an extra $2.2 billion in funding from project partners that also includes global clean technology companies.  Sustainable Development Technology Canada (SDTC) is energizing and evolving the development and demonstration of a clean technology ecosystem. They are the vital contributors to the prominent concentration of clean...